Ann: New Cancer Vaccine Trial Data presented at ASCO 2019, page-2

Just to silence all those who wrote IMU is crap:

1. " The study is ongoing with patients continuing to receive HER-Vaxx every 3 months to maintain highlevels of cancer targeting antibodies."

Without HER-Vaxx they would be dead already and look, some are still alive and kicking - what more proof does anyone need to see that the immune system got stimulated in a way that is had secured survival !!!!!!!!!!!!!

2. " Imugene Managing Director and Chief Executive Officer Leslie Chong said, “There is continuedinterest in the positive data from our Phase Ib trial which clearly supports our B-cell platformcancer vaccine strategy for treating HER-2 positive gastric cancer.”

I trust IMU comments only, that's what my investment is based on.

GLTA and there is finally a real chance for a cure !!!!!!!!!!!!!